Professor Matthew Disney and colleagues have been awarded $7.2 million from the National Institute of Neurological Disorders and Stroke.
Optimized immunizations reliably elicit protective antibodies in preclinical study, marking an important milestone on the way to an effective HIV vaccine.
Scripps Florida scientists have improved a state-of-the-art gene-editing technology to advance the system’s ability to target, cut and paste genes within human and animal cells.